On Tuesday, Zai Lab Limited ADR (NASDAQ: ZLAB) was 9.49% up from the session before settling in for the closing price of $29.71. A 52-week range for ZLAB has been $14.48 – $39.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 118.89% over the past five years. When this article was written, the company’s average yearly earnings per share was at 43.20%. With a float of $108.60 million, this company’s outstanding shares have now reached $109.64 million.
Let’s look at the performance matrix of the company that is accounted for 1869 employees. In terms of profitability, gross margin is 62.94%, operating margin of -70.71%, and the pretax margin is -64.44%.
Zai Lab Limited ADR (ZLAB) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Zai Lab Limited ADR stocks. The insider ownership of Zai Lab Limited ADR is 0.94%, while institutional ownership is 50.91%. The most recent insider transaction that took place on Apr 04 ’25, was worth 111,044. In this transaction an insider of this company sold 3,354 shares at a rate of $33.11, taking the stock ownership to the 67,345 shares. Before that another transaction happened on Apr 04 ’25, when Company’s Chief Legal Officer sold 1,874 for $33.11, making the entire transaction worth $62,044. This insider now owns 30,375 shares in total.
Zai Lab Limited ADR (ZLAB) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.20% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
You can see what Zai Lab Limited ADR (ZLAB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.60, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach 0.25 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
Zai Lab Limited ADR (NASDAQ: ZLAB) saw its 5-day average volume 1.15 million, a positive change from its year-to-date volume of 1.09 million. As of the previous 9 days, the stock’s Stochastic %D was 66.45%. Additionally, its Average True Range was 2.63.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 54.61%, which indicates a significant decrease from 61.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 133.83% in the past 14 days, which was higher than the 69.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.07, while its 200-day Moving Average is $26.20. Nevertheless, the first resistance level for the watch stands at $33.11 in the near term. At $33.69, the stock is likely to face the second major resistance level. The third major resistance level sits at $34.68. If the price goes on to break the first support level at $31.54, it is likely to go to the next support level at $30.55. Assuming the price breaks the second support level, the third support level stands at $29.97.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
There are 109,628K outstanding shares of the company, which has a market capitalization of 3.57 billion. As of now, sales total 398,990 K while income totals -257,100 K. Its latest quarter income was 109,070 K while its last quarter net income were -81,680 K.
